Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 4
1980 1
1981 3
1982 3
1983 1
1984 4
1985 2
1986 5
1987 1
1989 6
1991 7
1992 2
1994 2
1998 2
1999 1
2001 1
2002 3
2004 2
2005 6
2006 4
2007 3
2008 2
2009 3
2010 2
2011 6
2012 3
2013 1
2014 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N. Becker MA, et al. Among authors: wortmann rl. N Engl J Med. 2005 Dec 8;353(23):2450-61. doi: 10.1056/NEJMoa050373. N Engl J Med. 2005. PMID: 16339094 Free article. Clinical Trial.
Noninflammatory myopathies.
Baer AN, Wortmann RL. Baer AN, et al. Among authors: wortmann rl. Rheum Dis Clin North Am. 2013 May;39(2):457-79. doi: 10.1016/j.rdc.2013.02.006. Epub 2013 Mar 16. Rheum Dis Clin North Am. 2013. PMID: 23597974 Review.
Dermatomyositis.
Callen JP, Wortmann RL. Callen JP, et al. Among authors: wortmann rl. Clin Dermatol. 2006 Sep-Oct;24(5):363-73. doi: 10.1016/j.clindermatol.2006.07.001. Clin Dermatol. 2006. PMID: 16966018 Review.
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR Jr, Becker MA, Wortmann RL, Macdonald PA, Hunt B, Streit J, Lademacher C, Joseph-Ridge N. Schumacher HR Jr, et al. Among authors: wortmann rl. Arthritis Rheum. 2008 Nov 15;59(11):1540-8. doi: 10.1002/art.24209. Arthritis Rheum. 2008. PMID: 18975369 Free article. Clinical Trial.
Preface: myopathies.
Wortmann RL. Wortmann RL. Rheum Dis Clin North Am. 2011 May;37(2):ix-x. doi: 10.1016/j.rdc.2011.02.001. Rheum Dis Clin North Am. 2011. PMID: 21444015 No abstract available.
Drug-induced myopathies.
Mor A, Mitnick HJ, Pillinger MH, Wortmann RL. Mor A, et al. Among authors: wortmann rl. Bull NYU Hosp Jt Dis. 2009;67(4):358-69. Bull NYU Hosp Jt Dis. 2009. PMID: 20001939 Review.
Gout and hyperuricemia.
Wortmann RL. Wortmann RL. Curr Opin Rheumatol. 2002 May;14(3):281-6. doi: 10.1097/00002281-200205000-00015. Curr Opin Rheumatol. 2002. PMID: 11981327 Review.
Drugs causing muscle disease.
Mor A, Wortmann RL, Mitnick HJ, Pillinger MH. Mor A, et al. Among authors: wortmann rl. Rheum Dis Clin North Am. 2011 May;37(2):219-31, vi. doi: 10.1016/j.rdc.2011.01.005. Rheum Dis Clin North Am. 2011. PMID: 21444021 Review.
The causes of drug-induced muscle toxicity.
Jones JD, Kirsch HL, Wortmann RL, Pillinger MH. Jones JD, et al. Among authors: wortmann rl. Curr Opin Rheumatol. 2014 Nov;26(6):697-703. doi: 10.1097/BOR.0000000000000108. Curr Opin Rheumatol. 2014. PMID: 25191992 Review.
Myotoxicity associated with lipid-lowering drugs.
Baer AN, Wortmann RL. Baer AN, et al. Among authors: wortmann rl. Curr Opin Rheumatol. 2007 Jan;19(1):67-73. doi: 10.1097/BOR.0b013e328010c559. Curr Opin Rheumatol. 2007. PMID: 17143099 Review.
81 results